Capital Flow Monitor · Sponsors · CIK 2076816
Red Cell Incubation Fund II, L.P.
1800 TYSONS BLVD, SUITE 900, MCLEAN, VA, 22102 · 650-843-5000
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2025
Fit score
—
Offering
—
Sold
$87.0M
% sold
—
Investors
32
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | D/A ·current | 506(b) | — | $87.0M | — | 32 | EDGAR ↗ |
| 2025-08-07 | D | 506(b) | $750.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Red Cell Incubation II GP, LLC — Director, McLean, VA
- N/A Red Cell Partners, LLC — Director, McLean, VA
- Grant Verstandig — Director, McLean, VA
-
Roger Ferguson — Director, McLean, VA
2 other raises
- Notarize, Inc. $56.4M of $130.4M · 43.2%
- VitaKey Inc. $0 of $43.5M · 0.0%
- John Tiernan — Executive Officer, McLean, VA
Placement agents
- Park Lane Ibs, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.